Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

COMPQX Closes Below Long Term Uptrend Line

Published 06/28/2017, 08:56 AM
Updated 07/09/2023, 06:31 AM

Short Term Trends Remain Neutral

Opinion: All of the indexes closed lower yesterday with negative internals on the NYSE and NASDAQ as volumes rose from the prior session. No technical support levels were violated although the COMPQX closed below its long term uptrend line. The data remains largely neutral and uninstructive at this stage. We are maintaining our “negative” near term outlook for the major indexes as extended valuation, high levels of margin debt and advisor complacency combine to suggest risk well outweighs reward at current levels.

  • On the charts, all of the indexes closed lower yesterday with broadly negative internals on rising volume. However, in spite of the declines, no support levels were violated on the charts leaving all of the near term trends neutral. The SPX (page 2) did close on support that would be violated should weakness continue. The one technical event occurring which we find worthy of note was the COMPQX (page 3) closing below its long term uptrend line for the first time since the initiation of the rally from last November. It is, in our opinion, a sign of caution. However, we would need to see a violation of support for the picture to turn negative.
  • The data is little changed and largely neutral. All of the McClellan OB/OS Oscillators remain neutral (All Exchange:-13.28/+15.9 NYSE:-15.33/+28.7 NASDAQ:-12.05/+4.26) as are the Total (0.77) and Equity (0.6) Put/Call Ratios. The Open Insider Buy/Sell Ratio is also neutral at 48.2 while the OEX Put/Call Ratio has turned bullish at 0.74 as the pros bought calls expecting some bounce from yesterday’s declines.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
  • In conclusion, while the charts and data continue to suggest a rather neutral outlook, we remain of the opinion that a high level of risk is present versus potential reward as the forward valuation of the SPX at an 18.1 multiple (0.2 from a decade high) combined with heavy margin exposure (up 20.5% y/y) and the Investors Intelligence Bear/Bull Ratio (contrary indicator) at 19.4/51.0 implying complacency on their part combine to suggest appreciable downside risk is present should an event occur that could cause a shift in sentiment. Republican failure to pass a healthcare bill putting proposed tax cuts in jeopardy could be such an event. Such shifts are far from uncommon in market history. And when they happen with the above combination in place, the result can be far more impactful than one might otherwise expect.
  • Forward 12 month earnings estimates for the SPX from IBES of $133..96 leave a 5.55 forward earnings yield on a 18.1 forward multiple, near a decade high.

SPX: 2,420/NA

DJI: 21,042/NA

COMPQX: 6,121/6,304

DJT: 9,160/9,487

MID: 1,715/NA

RTY: 1,392/1,419

VALUA: 5,447/5,550

Latest comments

The best way for you
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.